Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...
BioForge and Panther Life Sciences explain how their partnership is advancing vaccine patch technology and keeping the ...
Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology Research builds on Emory’s ...
The clinical study aims to evaluate a vaccine for avian influenza A (H7N9) delivered by Vaxxas’ high-density microarray patch (HD-MAP), and is funded by the United States government as a potential ...
[Image from Micron Biomedical website] Micron Biomedical announced today that it added $16 million in funding to bring its Series A equity round to more than $33 million. J2 Ventures and the Global ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Amorphous solid dispersions (ASDs) offer a well-recognized strategy to improve the ...
Drug discovery is a long and challenging process, often slowed by traditional screening methods. Small molecule microarrays (SMM) offer a high-throughput, efficient method to identify potential small ...
As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results